17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.
about
The genome of the myxosporean Thelohanellus kitauei shows adaptations to nutrient acquisition within its fish host.Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1Comparative proteomic analysis of hypertrophic chondrocytes in osteoarthritis.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.MiR-152 Regulates Apoptosis and Triglyceride Production in MECs via Targeting ACAA2 and HSD17B12 Genes.
P2860
17β Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
17β Hydroxysteroid dehydrogena ...... rognosis in ovarian carcinoma.
@ast
17β Hydroxysteroid dehydrogena ...... rognosis in ovarian carcinoma.
@en
type
label
17β Hydroxysteroid dehydrogena ...... rognosis in ovarian carcinoma.
@ast
17β Hydroxysteroid dehydrogena ...... rognosis in ovarian carcinoma.
@en
prefLabel
17β Hydroxysteroid dehydrogena ...... rognosis in ovarian carcinoma.
@ast
17β Hydroxysteroid dehydrogena ...... rognosis in ovarian carcinoma.
@en
P2093
P2860
P1433
P1476
17β Hydroxysteroid dehydrogena ...... rognosis in ovarian carcinoma.
@en
P2093
Albert B DeLeo
Carmen Visus
Diana Lenzner
Esther Elishaev
Maciej Zabel
Marta Glura
Marta Szajnik
Miroslaw J Szczepanski
Theresa L Whiteside
P2860
P304
P356
10.1016/J.YGYNO.2012.08.010
P407
P577
2012-08-17T00:00:00Z